5191 -- To direct the Under Secretary of Defense for Research and Engineering to issue guidance for private entities on demonstrating how biobased products meet Department of Defense requirements, and for other purposes. | Poliscope

To direct the Under Secretary of Defense for Research and Engineering to issue guidance for private entities on demonstrating how biobased products meet Department of Defense requirements, and for other purposes.

5191

119th Congress

Armed Forces and National Security

In Committee

Legislative Progress

✓

Introduced

Committee

Floor Vote

Other Chamber

Enacted

Introduced

September 8, 2025

Latest Action

September 8, 2025

Primary Sponsor

Ro KhannaDemocratic(CA)

Momentum (last 30 days)

score

0 actions · 0 new cosponsors · 0 votes

Speed vs cohort

0pct

0d open

vs 10,940 other HR bills in the 119th — cohort avg 30d

Summary

No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.

Actions (2)

September 8, 2025

Referred to the House Committee on Armed Services.

September 8, 2025

Introduced in House

Congress.gov source codes: 1000, Intro-H

Committees

Committee	Chamber	Activity	Date
Armed Services Committee	House	Referred To	September 8, 2025

Text Versions

Version	Date	Links
Introduced in House	September 8, 2025	XML

Cosponsors (2)

Name	Party	State
Donald G. Davis	Democratic	NC
John Garamendi	Democratic	CA

Related Bills (1)

Bill	Congress	Relationship
HR 3838	119th	Related bill

Similar Bills (AI)

Bills with similar content found using semantic analysis.

5186

119th

76%

To authorize the Secretary of Defense to carry out a program to support the defense biotechnology supply chain, and for other purposes.

6664

119th

75%

To establish a Biotechnology Management Office in the Department of Defense and to provide support for the research and development of bioindustrial manufacturing processes, and for other purposes.

5187

119th

72%

To establish in the Department of Defense a program to support the expansion of domestic bioindustrial manufacturing capacity.

Sources: Congress.gov